Annual Accounts Payable
$4.74 M
-$1.27 M-21.09%
31 December 2023
Summary:
Structure Therapeutics American Depositary Shares annual accounts payable is currently $4.74 million, with the most recent change of -$1.27 million (-21.09%) on 31 December 2023. During the last 3 years, it has risen by +$3.21 million (+210.54%). GPCR annual accounts payable is now -21.09% below its all-time high of $6.01 million, reached on 31 December 2022.GPCR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$8.45 M
+$6.24 M+282.39%
30 September 2024
Summary:
Structure Therapeutics American Depositary Shares quarterly accounts payable is currently $8.45 million, with the most recent change of +$6.24 million (+282.39%) on 30 September 2024. Over the past year, it has increased by +$5.13 million (+154.50%). GPCR quarterly accounts payable is now at all-time high.GPCR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GPCR Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -21.1% | +154.5% |
| 3 y3 years | +210.5% | +142.4% |
| 5 y5 years | - | - |
GPCR Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -21.1% | +210.5% | at high | +282.4% |
| 5 y | 5 years | -21.1% | +210.5% | at high | +282.4% |
| alltime | all time | -21.1% | +210.5% | at high | +282.4% |
Structure Therapeutics American Depositary Shares Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $8.45 M(+282.4%) |
| June 2024 | - | $2.21 M(-66.2%) |
| Mar 2024 | - | $6.54 M(+37.9%) |
| Dec 2023 | $4.74 M | $4.74 M(+42.9%) |
| Sept 2023 | - | $3.32 M(-41.8%) |
| June 2023 | - | $5.70 M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $4.95 M(-17.7%) |
| Dec 2022 | $6.01 M(+72.5%) | $6.01 M(+5.4%) |
| Sept 2022 | - | $5.70 M(+63.7%) |
| Dec 2021 | $3.48 M(+128.2%) | - |
| Dec 2021 | - | $3.48 M |
| Dec 2020 | $1.53 M | - |
FAQ
- What is Structure Therapeutics American Depositary Shares annual accounts payable?
- What is the all time high annual accounts payable for Structure Therapeutics American Depositary Shares?
- What is Structure Therapeutics American Depositary Shares annual accounts payable year-on-year change?
- What is Structure Therapeutics American Depositary Shares quarterly accounts payable?
- What is the all time high quarterly accounts payable for Structure Therapeutics American Depositary Shares?
- What is Structure Therapeutics American Depositary Shares quarterly accounts payable year-on-year change?
What is Structure Therapeutics American Depositary Shares annual accounts payable?
The current annual accounts payable of GPCR is $4.74 M
What is the all time high annual accounts payable for Structure Therapeutics American Depositary Shares?
Structure Therapeutics American Depositary Shares all-time high annual accounts payable is $6.01 M
What is Structure Therapeutics American Depositary Shares annual accounts payable year-on-year change?
Over the past year, GPCR annual accounts payable has changed by -$1.27 M (-21.09%)
What is Structure Therapeutics American Depositary Shares quarterly accounts payable?
The current quarterly accounts payable of GPCR is $8.45 M
What is the all time high quarterly accounts payable for Structure Therapeutics American Depositary Shares?
Structure Therapeutics American Depositary Shares all-time high quarterly accounts payable is $8.45 M
What is Structure Therapeutics American Depositary Shares quarterly accounts payable year-on-year change?
Over the past year, GPCR quarterly accounts payable has changed by +$5.13 M (+154.50%)